Synthesis and in Vivo Biological Evaluation of 68Ga-Labeled Carbonic Anhydrase IX Targeting Small Molecules for Positron Emission Tomography D Sneddon, R Niemans, M Bauwens, A Yaromina, SJA Van Kuijk, ... Journal of medicinal chemistry 59 (13), 6431-6443, 2016 | 41 | 2016 |
Chlorambucil targets BRCA 1/2‐deficient tumours and counteracts PARP inhibitor resistance EMC Tacconi, S Badie, G De Gregoriis, T Reisländer, X Lai, M Porru, ... EMBO molecular medicine 11 (7), e9982, 2019 | 35 | 2019 |
Emerging chelators for nuclear imaging D Sneddon, B Cornelissen Current Opinion in Chemical Biology 63, 152-162, 2021 | 31 | 2021 |
Development and pre-clinical testing of a novel hypoxia-activated KDAC inhibitor A Skwarska, EDD Calder, D Sneddon, H Bolland, ML Odyniec, IN Mistry, ... Cell chemical biology 28 (9), 1258-1270. e13, 2021 | 27 | 2021 |
Selective NaOH-catalysed hydration of aromatic nitriles to amides TE Schmid, A Gómez-Herrera, O Songis, D Sneddon, A Révolte, F Nahra, ... Catalysis Science & Technology 5 (5), 2865-2868, 2015 | 22 | 2015 |
Hypoxia-activated pro-drugs of the KDAC inhibitor vorinostat (SAHA) EDD Calder, A Skwarska, D Sneddon, LK Folkes, IN Mistry, SJ Conway, ... Tetrahedron 76 (21), 131170, 2020 | 21 | 2020 |
Agents described in the Molecular Imaging and Contrast Agent Database for imaging carbonic anhydrase IX expression D Sneddon, SA Poulsen Journal of enzyme inhibition and medicinal chemistry 29 (5), 753-763, 2014 | 20 | 2014 |
A model system to explore the detection limits of antibody-based immuno-SPECT imaging of exclusively intranuclear epitopes M Veal, G Dias, V Kersemans, D Sneddon, S Faulkner, B Cornelissen Journal of Nuclear Medicine 62 (11), 1537-1544, 2021 | 8 | 2021 |
Zap‐Pano: a Photocaged Prodrug of the KDAC Inhibitor Panobinostat KS Troelsen, EDD Calder, A Skwarska, D Sneddon, EM Hammond, ... ChemMedChem 16 (24), 3691-3700, 2021 | 6 | 2021 |
The design, synthesis, and evaluation of hypoxia-activated prodrugs of the KDAC inhibitor panobinostat E Calder, A Skwarska, D Sneddon, L Folkes, IN Mistry, EM Hammond, ... | | 2020 |
Exploring the limits of intranuclear PET/SPECT imaging with IgG-TAT: how low can you go? M Veal, GM Dias, V Kersemans, D Sneddon, S Faulkner, B Cornelissen EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 47 (SUPPL 1), S78-S78, 2020 | | 2020 |
Development of novel Ga-68 chelators for PET imaging D Sneddon, WT Stuber, S Faulkner, B Cornelissen EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46 (SUPPL 1 …, 2019 | | 2019 |
Development of novel 68Ga chelators for PET imaging D Sneddon, W Stuber, S Faulkner, B Cornelissen EANM'19, 2019 | | 2019 |
Prospects of 31P Contrast Media for 31P-MRS LR Tear, ML Maguire, G Karunanithy, D Sneddon, NJ Farrer, A Baldwin, ... Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018, 2018 | | 2018 |
99mTc-duramycin imaging reveals variable tissue toxicity of cancer drugs D Sneddon, JBÃ Torres, S Badie, M Tarsounas, B Cornelissen Journal of Nuclear Medicine 59 (supplement 1), 1286-1286, 2018 | | 2018 |
DEVELOPMENT OF IMAGING AGENTS TO TARGET TUMOUR HYPOXIA D SNEDDON | | 2016 |
Catalysis Science & Technology RSCPublishing TE Schmid, A Gómez-Herrera, O Songis, D Sneddon, A Révolte, F Nahra, ... | | |